Skip to main
USPH

USPH Stock Forecast & Price Target

USPH Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 0%
Buy 100%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

US Physical Therapy has demonstrated a positive trend in commercial pricing, which increased sequentially by 2.2%, indicating a stable demand for its services. Additionally, the company's Industrial Injury Prevention (IIP) revenue surged by 22.2% overall and 18.4% when excluding merger and acquisition contributions, reflecting robust growth in its operational segments. Furthermore, the recently acquired Metro business has shown a significant improvement in its net rate, rising from approximately $101 to $107.50, suggesting effective integration and value generation from acquisitions.

Bears say

US Physical Therapy has experienced a persistent decline in a key financial metric, decreasing 0.6% to $83.95 over the past year. The company continues to face significant reimbursement cuts, accumulating to a $20 million detriment to profitability over the last five years, which raises concerns about the sustainability of its revenue streams. Additionally, the reported clinic and other expenses increased to 20.2% of revenue, slightly surpassing the estimated 20.1%, indicating potential challenges in cost management that could further impact financial performance.

USPH has been analyzed by 3 analysts, with a consensus rating of Buy. 0% of analysts recommend a Strong Buy, 100% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About U.S. Physical Therapy (USPH) Forecast

Analysts have given USPH a Buy based on their latest research and market trends.

According to 3 analysts, USPH has a Buy consensus rating as of Jan 2, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $105.33, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $105.33, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

U.S. Physical Therapy (USPH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.